Skip to content

Comparison of the Anesthetic Effects of Intravenous Remimazolam and Propofol in Gynecological Day Surgery: A Randomized Non-inferiority Study

Comparison of the Anesthetic Effects of Intravenous Remimazolam and Propofol in Gynecological Day Surgery: A Randomized Non-inferiority Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097124
Enrollment
Unknown
Registered
2025-02-12
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Remazolam group:Remazolam 0.25mg/kg, 1 minute limited infusion
After sleeping, 0.2mg/kg of micuronium was injected within 30 seconds, and 20ug/kg of afentanil was injected within 30 seconds. The laryngeal mask was inserted and the anesthesia machine was used to c
Propofol group:Propofol 2mg/kg, 1 minute limited infusion

Sponsors

Weifang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Females aged 18-65 years; 2. Body mass index (BMI) 18-30kg/m^2; 3. ASAI-II level; 4. Patients who intend to undergo gynecological day hysteroscopic surgery under intravenous general anesthesia; 5. No heart and lung diseases, no liver and kidney dysfunction; 6. The patient has good compliance and voluntarily signs the informed consent form for anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients with obvious respiratory and circulatory dysfunction, abnormal liver and kidney function before surgery; 2. Those who are allergic or contraindicated to benzodiazepines, propofol, opioids and their components; 3. Patients with severe neuropsychiatric diseases and patients who have been taking antidepressants, anxiolytics or other psychotropic drugs for a long time (more than 3 months); 4. Patients with severe hypertension (SBP>180mmHg or DBP>100mmmHg after admission).

Design outcomes

Primary

MeasureTime frame
Success rate of anesthesia;

Secondary

MeasureTime frame
Time to sleep induced by anesthesia;Time to recover from anesthesia;Duration of anesthesia maintenance;Vital signs at different times ( blood pressure, heart rate, oxygen saturation [ SpO2 ], prtial pressure of end tidal carbon dioxide [PetCO2], respiration rate, [RR]);Adverse events during anesthesia induction (injection pain, hiccup, cough, motility, hypertension, hypotension, tachycardia, bradycardia, etc.);Adverse events during anesthesia maintenance (hiccup, motility, cough, hypertension, hypotension, tachycardia, bradycardia, etc.);PONV incidence;

Countries

China

Contacts

Public ContactJi Fanceng

Weifang People's Hospital

Jifanceng@163.com+86 135 6369 8838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026